AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene
Authors: Taschner, PEM Jansen, JC Baysal, BE Bosch, A Rosenberg, EH Brocker-Vriends, AHJT van der Mey, AGL van Ommen, GJB Cornelisse, CJ Devilee, P
Citation: Pem. Taschner et al., Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene, GENE CHROM, 31(3), 2001, pp. 274-281
Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors
Authors: Van der Looij, M Papp, J Sztan, M Pulay, T Elfadil, I Besznyak, I Toth, J Devilee, P Olah, E
Citation: M. Van Der Looij et al., Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors, INT J ONCOL, 18(4), 2001, pp. 775-780
Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing
Authors: Lodder, L Frets, PG Trijsburg, RW Tibben, A Meijers-Heijboer, EJ Duivenvoorden, HJ Wagner, A van der Meer, CA Devilee, P Cornelisse, CJ Niermeijer, MF
Citation: L. Lodder et al., Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing, EUR J HUM G, 9(7), 2001, pp. 492-500
A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-MbBAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region
Authors: Baysal, BE Willett-Brozick, JE Taschner, PEM Dauwerse, JG Devilee, P Devlin, B
Citation: Be. Baysal et al., A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-MbBAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region, EUR J HUM G, 9(2), 2001, pp. 121-129
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families
Authors: Verhoog, LC van den Ouweland, AMW Berns, E van Veghel-Plandsoen, MM van Staveren, IL Wagner, A Bartels, CCM Tilanus-Linthorst, MMA Devilee, P Seynaeve, C Halley, DJJ Niermeijer, MF Klijn, JGM Meijers-Heijboer, H
Citation: Lc. Verhoog et al., Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families, EUR J CANC, 37(16), 2001, pp. 2082-2090
A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage
Authors: Hohenstein, P Kielman, MF Breukel, C Bennett, LM Wiseman, R Krimpenfort, P Cornelisse, G van Ommen, GJ Devilee, P Fodde, R
Citation: P. Hohenstein et al., A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage, ONCOGENE, 20(20), 2001, pp. 2544-2550
A partial BRCA1 sequence homology mapping to 4q28
Authors: Stec, I van Vliet, M van Eijk, R Meijers, H Kroeze, KHG Dauwerse, JG van Ommen, GJB Cornelisse, CJ den Dunnen, JT Devilee, P
Citation: I. Stec et al., A partial BRCA1 sequence homology mapping to 4q28, CYTOG C GEN, 94(1-2), 2001, pp. 26-29
Ever since Knudson
Authors: Devilee, P Cleton-Jansen, AM Cornelisse, CJ
Citation: P. Devilee et al., Ever since Knudson, TRENDS GEN, 17(10), 2001, pp. 569-573
Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients
Authors: de Bock, GH Tollenaar, RAEM Papelard, H Cornelisse, CJ Devilee, P van de Vijver, MJ
Citation: Gh. De Bock et al., Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients, BR J CANC, 85(9), 2001, pp. 1347-1350
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases
Authors: Bonsing, BA Corver, WE Fleuren, GJ Cleton-Jansen, AM Devilee, P Cornelisse, CJ
Citation: Ba. Bonsing et al., Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases, GENE CHROM, 28(2), 2000, pp. 173-183
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1
Authors: van der Looij, M Cleton-Jansen, AM van Eijk, R Morreau, H van Vliet, M Kuipers-Dijkshoorn, N Olah, E Cornelisse, CJ Devilee, P
Citation: M. Van Der Looij et al., A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1, GENE CHROM, 27(3), 2000, pp. 295-302
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22
Authors: Rahman, N Teare, MD Seal, S Renard, H Mangion, J Cour, C Thompson, D Shugart, Y Eccles, D Devilee, P Meijers, H Nathanson, KL Neuhausen, SL Weber, B Chang-Claude, J Easton, DF Goldgar, D Stratton, MR
Citation: N. Rahman et al., Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22, ONCOGENE, 19(36), 2000, pp. 4170-4173
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation, LANCET, 355(9220), 2000, pp. 2015-2020
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
Authors: Baysal, BE Ferrell, RE Willett-Brozick, JE Lawrence, EC Myssiorek, D Bosch, A van der Mey, A Taschner, PEM Rubinstein, WS Myers, EN Richard, CW Cornelisse, CJ Devilee, P Devlin, B
Citation: Be. Baysal et al., Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, SCIENCE, 287(5454), 2000, pp. 848-851
Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis
Authors: Peelen, T de Leeuw, W van Lent, K Morreau, H van Eijk, R van Vliet, M Wijnen, J Ligtenberg, M Ginjaar, HB Zweemer, R Menko, F Fodde, R van Ommen, GJB Vasen, HFA Cornelisse, CJ Devilee, P
Citation: T. Peelen et al., Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis, INT J CANC, 88(5), 2000, pp. 778-782
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
Authors: Van der Looij, M Szabo, C Besznyak, I Liszka, G Csokay, B Pulay, T Toth, J Devilee, P King, MC Olah, E
Citation: M. Van Der Looij et al., Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary, INT J CANC, 86(5), 2000, pp. 737-740
Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation
Authors: Meijers-Heijboer, EJ Verhoog, LC Brekelmans, CTM Seynaeve, C Tilanus-Linthorst, MMA Wagner, A Dukel, L Devilee, P van den Ouweland, AMW van Geel, AN Klijn, JGM
Citation: Ej. Meijers-heijboer et al., Genetic testing and prophylactic surgery in familiar clusters of BRCA1 or BRCA2 mutation, GYNAKOLOGE, 33(10), 2000, pp. 768-769
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer
Authors: Berns, EMJJ Foekens, JA Vossen, R Look, MP Devilee, P Henzen-Logmans, SC van Staveren, IL van Putten, WLJ Inganas, M Meijer-van Gelder, ME Cornelisse, C Claassen, CJC Portengen, H Bakker, B Klijn, JGM
Citation: Emjj. Berns et al., Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer, CANCER RES, 60(8), 2000, pp. 2155-2162
Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients
Authors: Papelard, H de Bock, GH van Eijk, R Vlieland, TPMV Cornelisse, CJ Devilee, P Tollenaar, RAEM
Citation: H. Papelard et al., Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients, BR J CANC, 83(6), 2000, pp. 719-724
Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families
Authors: Peelen, T van Vliet, M Bosch, A Bignell, G Vasen, HFA Klijn, JGM Meijers-Heijboer, H Stratton, M van Ommen, GJB Cornelisse, CJ Devilee, P
Citation: T. Peelen et al., Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families, BR J CANC, 82(1), 2000, pp. 151-156
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility
Authors: Broeks, A Urbanus, JHM Floore, AN Dahler, EC Klijn, JGM Rutgers, EJT Devilee, P Russell, NS van Leeuwen, FE van't Veer, LJ
Citation: A. Broeks et al., ATM-heterozygous germline mutations contribute to breast cancer-susceptibility, AM J HU GEN, 66(2), 2000, pp. 494-500
Survival in hereditary breast cancer associated with germline mutations ofBRCA2
Authors: Verhoog, LC Brekelmans, CTM Seynaeve, C Dahmen, G van Geel, AN Bartels, CCM Tilanus-Linthorst, MMA Wagner, A Devilee, P Halley, DJJ van den Ouweland, AMW Meijers-Heijboer, EJ Klijn, JGM
Citation: Lc. Verhoog et al., Survival in hereditary breast cancer associated with germline mutations ofBRCA2, J CL ONCOL, 17(11), 1999, pp. 3396-3402
Genomic structure of the human PLZF gene
Authors: van Schothorst, EM Prins, DEM Baysal, BE Beekman, M Licht, JD Waxman, S Zelent, A Cornelisse, CJ van Ommen, GJB Richard, CW Devilee, P
Citation: Em. Van Schothorst et al., Genomic structure of the human PLZF gene, GENE, 236(1), 1999, pp. 21-24
Risultati: 1-25 | 26-34